the importance of mrd as a prognostic tool in multiple myeloma
Published 11 months ago • 141 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
2:24
the importance of mrd in multiple myeloma patients
-
1:15
the importance of mrd in multiple myeloma management
-
4:16
the prognostic value of mrd in multiple myeloma & mrd-guided therapy
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies
-
2:17
mrd: a promising biomarker in multiple myeloma
-
1:44
the value of mrd as an early endpoint in multiple myeloma clinical trials
-
0:48
myeloma prognosis - the emergence of mrd
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
10:32
multiple myeloma (bone marrow cancer), ascites, pleural effusion - patient review !!
-
9:25
mgus diagnosis: a step-by-step approach
-
1:26
incidence and risk factors associated with vod/sos in younger vs older adults after sct
-
1:30
mrd: an important topic in myeloma therapy
-
2:11
mrd as a predictor of risk in myeloma
-
1:27
the real world utilization of mrd in myeloma across europe
-
6:33
mrd as a tool to discontinue therapy in mm?
-
1:20
mrd in myeloma
-
1:26
mrd in myeloma: the fda perspective
-
3:15
the evolution of mrd for myeloma
-
3:01
the benefit of using mrd to guide treatment decisions in multiple myeloma
-
8:42
assessing mrd in multiple myeloma
-
1:37
the next steps and updated guidelines for the use of mrd concepts in multiple myeloma
-
0:52
mrd for multiple myeloma: is it ready for prime-time?